K-LYTE CL 1.86 G / 7.8 G
POTASSIUM CHLORIDE : 1.86 G / 7.8 G · DIN 02089580 · WELLSPRING PHARMACEUTICAL CANADA CORP
Health Canada status: CANCELLED POST MARKET
What is K-LYTE CL?
K-LYTE CL 1.86 G / 7.8 G contains POTASSIUM CHLORIDE : 1.86 G / 7.8 G. It is listed in the Health Canada Drug Product Database under DIN 02089580, held by WELLSPRING PHARMACEUTICAL CANADA CORP, supplied as POWDER FOR SOLUTION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 23-Feb-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02089580 |
|---|---|
| Brand name | K-LYTE CL |
| Generic / active ingredient | POTASSIUM CHLORIDE : 1.86 G / 7.8 G |
| Manufacturer | WELLSPRING PHARMACEUTICAL CANADA CORP |
| Strength | 1.86 G / 7.8 G |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | ORAL |
| Schedule | Ethical |
| ATC code | A12BA01 POTASSIUM CHLORIDE |
| AHFS class | 40:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 23-Feb-2009 |
| Original market date | 1995-12-31 00:00:00 |
Is POTASSIUM CHLORIDE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code A12BA01 POTASSIUM CHLORIDE. 1 of 21 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| POTASSIUM CHLORIDE FOR HEMODIALYSIS 7.55 | 7.55 G | POWDER FOR SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | DIN 02529793 |
| HI POTENCY POTASSIUM CHLORIDE | 500 MG | TABLET (SLOW-RELEASE) | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | DIN 02230588 |
| K C1-ROUGIER | 750 MG / 15 ML | LIQUID | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | CANCELLED POST MARKET | DIN 00026808 |
| K LOR GRANULES 20MEQ | 1.5 G / 3 G | POWDER FOR SOLUTION | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | DIN 00481211 |
| K LYTE CL PWR | 1.86 G / 7.8 G | POWDER FOR SOLUTION | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | CANCELLED POST MARKET | DIN 00464813 |
| K-DUR | 1.5 G | TABLET (EXTENDED-RELEASE) | MERCK CANADA INC | CANCELLED POST MARKET | DIN 00713376 |
| K-MED 900 TAB 900MG | 900 MG | TABLET | LABORATOIRE RIVA INC. | CANCELLED POST MARKET | DIN 00810231 |
| KALIUM DURULES SRT 750MG | 750 MG | TABLET (EXTENDED-RELEASE) | ASTRA PHARMA INC. | CANCELLED POST MARKET | DIN 00471496 |
| KAOCHLOR-10 | 10 % | SOLUTION | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02063859 |
| KAOCHLOR-20 | 3 G / 15 ML | SOLUTION | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02064502 |
Who else supplies POTASSIUM CHLORIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. POTASSIUM CHLORIDE appears in 158 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.